Literature DB >> 28466973

Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.

Henrik Støvring1, Anton Pottegård2, Jesper Hallas2.   

Abstract

PURPOSE: The study aimed to develop an automated method to estimate prescription durations in pharmacoepidemiological studies that may depend on patient and redemption characteristics.
METHODS: We developed an estimation algorithm based on maximum likelihood estimation for the reverse waiting time distribution (WTD), which is the distribution of time from the last prescription of each patient within a time window to the end of the time window. The reverse WTD consists of two distinctly different components: one component for prevalent users and one for patients stopping treatment. We extended the model to allow parameters of the reverse WTD to depend on linear combinations of covariates to obtain estimates and confidence intervals for percentiles of the inter-arrival density (time from one prescription to the subsequent). We applied the method to redemptions of warfarin, using the amount of drug filled, patient sex and patient age as covariates.
RESULTS: The estimated prescription durations increased with redeemed amount and age. Women generally had longer prescription durations, which increased more with age than men. For 70-year-old women redeeming 300+ pills, we predicted a 95th percentile of the inter-arrival density of 225 (95%CI: 201, 249) days. For 50-year-old men redeeming 100 pills, the corresponding prediction was 97 (88, 106) days.
CONCLUSIONS: The algorithm allows estimation of prescription durations based on the reverse WTD, which can depend upon observed covariates. Statistical uncertainty intervals and tests allow statistical inference on the influence of observed patient and prescription characteristics. The method may replace ad hoc decision rules.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  covariates; maximum likelihood; parametric modelling; pharmacoepidemiology; prescription durations; reverse waiting time distribution

Mesh:

Substances:

Year:  2017        PMID: 28466973     DOI: 10.1002/pds.4216

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Measurement error and misclassification in electronic medical records: methods to mitigate bias.

Authors:  Jessica C Young; Mitchell M Conover; Michele Jonsson Funk
Journal:  Curr Epidemiol Rep       Date:  2018-09-10

2. 

Authors:  Sinéad M Langan; Sigrún A J Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sørensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

Review 3.  Pharmacoepidemiological methods for computing the duration of pharmacological prescriptions using secondary data sources.

Authors:  Marianne Meaidi; Henrik Støvring; Klaus Rostgaard; Christian Torp-Pedersen; Kristian Hay Kragholm; Morten Andersen; Maurizio Sessa
Journal:  Eur J Clin Pharmacol       Date:  2021-07-10       Impact factor: 2.953

4.  The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).

Authors:  Sinéad M Langan; Sigrún Aj Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sorensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  BMJ       Date:  2018-11-14

5.  Incidence in pharmacoepidemiology-Basic definitions and types of misclassification.

Authors:  Mikael Hoffmann; Henrik Støvring
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-04-13       Impact factor: 3.688

6.  A flexible mixed-data model applied to claims data for post-market surveillance of prescription drug safety behavior.

Authors:  Harris Butler; John D Rice; Nichole E Carlson; Elaine H Morrato
Journal:  Pharm Stat       Date:  2022-04-03       Impact factor: 1.234

7.  A new likelihood model for analyses of pharmacoepidemiologic case-control studies which avoids decision rules for determining latent exposure status.

Authors:  Henrik Støvring; Anton Pottegård; Jesper Hallas
Journal:  BMC Med Res Methodol       Date:  2021-07-08       Impact factor: 4.615

Review 8.  Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries.

Authors:  Kristina Laugesen; Jonas F Ludvigsson; Morten Schmidt; Mika Gissler; Unnur Anna Valdimarsdottir; Astrid Lunde; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2021-07-19       Impact factor: 4.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.